Related Experiment Video
Updated: Jan 5, 2026

06:28
Isolation of Low Endotoxin Content Extracellular Vesicles Derived from Cancer Cell Lines
Published on: February 17, 2023
1.5K
Removal of Endotoxin from rAAV Samples Using a Simple Detergent-Based Protocol
Liudmyla Kondratova1, Oleksandr Kondratov1, Ragy Ragheb2
1Department of Pediatrics, Division of Cellular and Molecular Therapy, University of Florida, Gainesville 32610, FL, USA.
Molecular Therapy. Methods & Clinical Development
|October 26, 2019
Summary
Endotoxin contamination in recombinant adeno-associated virus (rAAV) stocks is a common issue. A new, simple protocol effectively removes endotoxin from rAAV vectors, preserving viral titer and ensuring safety.
Area of Science:
- Biotechnology
- Virology
- Molecular Biology
Background:
- Endotoxin is a frequent contaminant in protein and viral preparations, posing significant risks.
- Recombinant adeno-associated virus (rAAV) stocks often contain endotoxin, which can cause adverse reactions and complicate research.
- Existing endotoxin removal methods can lead to substantial loss of rAAV titer, especially with diverse serotypes.
Purpose of the Study:
- To develop a universal and efficient protocol for removing endotoxin from rAAV stocks.
- To ensure the safety and efficacy of rAAV vectors by reducing endotoxin levels.
- To maintain high viral recovery rates across different rAAV serotypes.
Main Methods:
- A simple protocol involving mild detergent treatment of endotoxin-contaminated rAAV.
- Repeated buffer-exchange washing to remove endotoxin.
- Concentration of purified viral stock using low-speed centrifugation.
Main Results:
- The protocol effectively reduces endotoxin levels from >1,000 EU/mL to <2.5 EU/mL.
- Viral titer recovery ranged from 50% to 100% after purification.
- Physical and biological equivalency of viral stocks was confirmed through multiple assays.
Conclusions:
- The described protocol offers a simple, universal solution for endotoxin removal from rAAV vectors.
- This method is effective across various rAAV serotypes and variants.
- The protocol successfully purifies rAAV stocks while maintaining high viral recovery and biological activity.

